ReviewActa myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology2026
Permanent weakness and myopathy in hypokalemic periodic paralysis.
Review in Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypokalemic periodic paralysis (HypoPP) is a rare disease that consists of attacks of flaccid paralysis that often occur at night or early in the morning. Some patients with HypoPP may develop permanent muscle weakness and permanent myopathy. Four phenotypes of disease have been described: 1) no symptoms; 2) periodic paralysis and absence of permanent weakness; 3) periodic paralysis and permanent paralysis; 4) permanent weakness and absence of periodic paralysis. Vacuolar alterations are present in the muscles of all patients affected by HypoPP. In general, vacuoles are heterogeneous in size and content. Vacuoles are present in both fiber types and are not exclusive to any muscle fiber type, age, or phenotype. Generally, vacuoles contain glycogen but may also contain autophagosomes, fibrillar proteins, central nuclei, and myofiber invaginations. Magnetic resonance shows that fat accumulation of various extension is present in the muscle of patients with HypoPP. Water accumulation may also be present whereas atrophy is limited. Fat accumulation tends to increase with time together with a decrease of muscle strength. Permanent weakness and myopathy impairs significantly the quality of life. No treatment is currently available. The aim of this review is to define the characteristics and outcome of permanent weakness and myopathy in patients with HypoPP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.